Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP
ACS Applied Materials & Interfaces · 2023
DOI: 10.1021/acsami.3c05374 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2023. Verfasst von Yuan Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Ovarian Neoplasms, Nanoparticles. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Harbin Medical University Cancer Hospital, National Natural Science Foundation of China, Heilongjiang Provincial Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
- Animal Laboratory Center, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150086, P.R. China.
- Laboratory of Controllable Preparation and Application of Nanomaterials, Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, No. 29 East Road Zhongguancun, Beijing 10…
- Department of Nuclear Medicine, Harbin Medical University Cancer Hospital, Nangang District, Harbin, Heilongjiang Province 150086, P.R. China.
ORCID-Profile: Xianwei Meng
Förderung
- Harbin Medical University Cancer Hospital
- National Natural Science Foundation of China
- Heilongjiang Provincial Postdoctoral Science Foundation
- National Key Research and Development Program of China
Zitieren
APA
Liu, Y., Wang, Y., Guan, X., Wu, Q., Zhang, M., Cui, P., Wang, C., Chen, X., Meng, X., & Ma, T. (2023). Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c05374
Vancouver
Liu Y, Wang Y, Guan X, Wu Q, Zhang M, Cui P, et al. Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c05374
BibTeX
@article{Liu2023,
author = {Liu, Yuan and Wang, Yiru and Guan, Xue and Wu, Qiong and Zhang, Mengjun and Cui, Ping and Wang, Can and Chen, Xiuwei and Meng, Xianwei and Ma, Tengchuang},
title = {Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
doi = {10.1021/acsami.3c05374}
}
EUVIMED